Filtros de búsqueda

Lista de obras de R Centis

A case of resistance beyond extensively drug-resistant tuberculosis in Japan

artículo científico publicado en 2013

A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium

artículo científico publicado en 2015

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium

artículo científico publicado en 2017

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

artículo científico publicado en 2009

Accelerating tuberculosis elimination in low-incidence settings: the role of genomics

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

scientific article published on 26 May 2020

Antituberculosis therapy and current global guidelines

Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.

artículo científico publicado en 2016

Availability of anti-tuberculosis drugs in Europe: Table 1–

scholarly article by Giovanni Sotgiu et al published 31 July 2012 in European Respiratory Journal

Bacille Calmette-Guerin vaccination: the current situation in Europe

article by M. Dara et al published 31 December 2013 in European Respiratory Journal

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2017

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

artículo científico publicado en 2016

Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use

scientific article published on 29 August 2013

Breaking the barriers: Migrants and tuberculosis

artículo científico publicado en 2017

Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease

artículo científico publicado en 2016

Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.

artículo científico publicado en 2016

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

artículo científico publicado en 2016

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

artículo científico publicado en 2017

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

artículo científico publicado en 2016

Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker.

artículo científico publicado en 2017

Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives

artículo científico publicado en 2016

Classifying new anti-tuberculosis drugs: rationale and future perspectives

artículo científico publicado en 2016

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

artículo científico publicado en 2017

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

artículo científico publicado en 2018

Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic

artículo científico publicado en 2020

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis

artículo científico publicado en 2009

Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data

artículo científico publicado en 2016

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

Compassionate and optimum use of new tuberculosis drugs.

artículo científico publicado en 2015

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges

artículo científico publicado en 2016

Consensus Not Yet Reached on Key Drugs for Extensively Drug‐Resistant Tuberculosis Treatment

scientific article published in 2009

Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.

artículo científico publicado en 2012

Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences

artículo científico publicado en 2017

Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe

artículo científico publicado en 2016

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey

artículo científico publicado en 2017

Declaration on palliative care for MDR/XDR-TB [Correspondence]

artículo científico publicado en 2012

Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis

artículo científico publicado en 2015

Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

artículo científico publicado en 2017

Development of a standardised tool to survey MDR-/XDR-TB case management in Europe

article

Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis

artículo científico publicado en 2017

Diagnostic performances of the Xpert MTB/RIF in Brazil

artículo científico publicado en 2017

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis

article

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

artículo científico publicado en 2012

Drug-resistant tuberculosis: past, present, future

artículo científico publicado en 2010

ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update.

artículo científico publicado en 2018

ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.

artículo científico publicado en 2014

ERS/WHO tuberculosis consilium: reporting of the initial 10 cases

artículo científico publicado en 2013

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2016

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

artículo científico publicado en 2017

Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil

artículo científico publicado en 2017

Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil.

artículo científico publicado en 2016

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

artículo científico publicado en 2012

Efficacy and tolerability of ethionamide versus prothionamide: a systematic review

artículo científico publicado en 2016

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

artículo científico publicado en 2012

Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives

artículo científico publicado en 2010

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for

scientific article published on 25 June 2020

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

scientific article published on 27 February 2009

Epidemiology of TB

scholarly article published December 2012

Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.

artículo científico publicado en 2015

Estrategias de la OMS para el tratamiento de la tuberculosis resistente

scholarly article by Adrián Rendon et al published March 2017 in Archivos de Bronconeumologia

European policies in the management of tuberculosis among migrants

artículo científico publicado en 2016

European union standards for tuberculosis care

artículo científico publicado en 2012

Extensively Drug-Resistant Tuberculosis Is Worse than Multidrug-Resistant Tuberculosis: Different Methodology and Settings, Same Results

scientific article published on 01 March 2008

Extensively drug-resistant tuberculosis: back to the future.

artículo científico publicado en 2010

Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis

artículo científico publicado en 2016

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

artículo científico publicado en 2016

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

artículo científico publicado en 2008

From the authors:

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis

scientific article published on 25 April 2019

Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.

artículo científico publicado en 2015

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

artículo científico publicado en 2016

Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination

scholarly article by Karapet Davtyan et al published 31 December 2014 in European Respiratory Journal

La diabetes se asocia con reacciones adversas graves en la tuberculosis multirresistente

article published in 2017

Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis

scholarly article by M. Villar et al published 31 August 2011 in European Respiratory Journal

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence

artículo científico publicado en 2013

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains

scholarly article by Giovanni Sotgiu et al published 31 December 2014 in European Respiratory Journal

MDR-TB and XDR-TB: drug resistance and treatment outcomes

artículo científico publicado en 2009

Management of drug resistantTB in patients with HIV co-infection

artículo científico publicado en 2015

Management of extensively drug-resistant tuberculosis

artículo científico publicado en 2017

Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal.

artículo científico publicado en 2015

Medical treatment of pulmonary tuberculosis

Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement

artículo científico publicado en 2012

Monitoring predictors of mortality: A necessary action to reach TB elimination.

artículo científico publicado en 2015

Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000.

artículo científico publicado en 2003

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion

artículo científico publicado en 2015

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

artículo científico publicado en 2012

Multidrug- and extensively drug-resistant TB in persons living with HIV.

artículo científico publicado en 2009

Multidrug- and extensively drug-resistant tuberculosis, Germany

artículo científico publicado en 2008

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

artículo científico publicado en 2007

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

artículo científico publicado en 2017

Multidrug-resistant tuberculosis today

artículo científico publicado en 2012

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.

artículo científico publicado en 2016

New anti-tuberculosis drugs and regimens: 2015 update

artículo científico publicado en 2015

New anti-tuberculosis drugs for special populations: a difficult-to-address issue

artículo científico publicado en 2016

New insights into TB from the 2010 European Respiratory Society annual conference

artículo científico publicado en 2011

Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination

artículo científico publicado en 2013

On linezolid efficacy and tolerability

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

artículo científico publicado en 2015

Preventing and controlling tuberculosis among refugees in Europe: more is needed

artículo científico publicado en 2016

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

artículo científico publicado en 2012

Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae

artículo científico publicado en 2019

Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.

artículo científico publicado en 2012

Recent developments in the diagnosis and management of tuberculosis

artículo científico publicado en 2016

Rediscovering high technology from the past: thoracic surgery is back on track for multidrug-resistant tuberculosis

artículo científico

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe

article

Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.

artículo científico publicado en 2017

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

artículo científico publicado en 2012

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

artículo científico publicado en 2008

Reversing the tuberculosis upwards trend: a success story in Romania

artículo científico publicado en 2009

Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa

artículo científico publicado en 2010

Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?

artículo científico publicado en 2017

Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs

artículo científico

Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?

artículo científico publicado en 2016

Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis

artículo científico publicado en 2017

Still dying in plain sight: missed and misclassified deaths due to tuberculosis in hospitals

scientific article published on 01 September 2019

Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium

artículo científico publicado en 2015

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

artículo científico publicado en 2019

TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel?

TB and MDR-TB: what is new in 2012?

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

artículo científico publicado en 2012

TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia

scholarly article by Laura Gillini et al published 14 March 2013 in Journal of Infection in Developing Countries

The best on infections: update from the 2010 ERS Congress

article

The challenge of the new tuberculosis drugs

artículo científico publicado en 2017

The multidrug-resistant tuberculosis threat: old problems and new solutions

artículo científico publicado en 2015

The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection.

artículo científico publicado en 2015

Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment

artículo científico publicado en 2015

Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?

artículo científico publicado en 2012

Towards tuberculosis elimination: an action framework for low-incidence countries

artículo científico publicado en 2015

Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices

artículo científico publicado en 2016

Tuberculosis control in prisons: current situation and research gaps

artículo científico publicado en 2015

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited.

artículo científico publicado en 2015

Tuberculosis elimination: dream or reality? The case of Cyprus

artículo científico publicado en 2014

Tuberculosis elimination: theory and practice in Europe

artículo científico publicado en 2014

Tuberculosis elimination: where are we now?

artículo científico publicado en 2018

Tuberculosis management and determinants of recurrence

scholarly article by Giovanni Sotgiu et al published 1 January 2016 in International Journal of Tuberculosis and Lung Disease

Tuberculosis treatment and drug regimens

artículo científico publicado en 2015

Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies

artículo científico

Tuberculosis, Public Health Aspects

article

Tuberculosis: an ancient and evergreen disease

artículo científico publicado en 2011

Understanding the multidrug-resistant tuberculosis epidemic in China

artículo científico publicado en 2017

Universal health coverage and social support in Senegal: a comprehensive approach against tuberculosis

artículo científico publicado en 2015

WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.

artículo científico publicado en 2016

WHO recommendations on shorter treatment of multidrug-resistant tuberculosis

artículo científico publicado en 2016

WHO strategies for the management of drug-resistant tuberculosis.

artículo científico publicado en 2016

WHO strategies for the programmatic management of drug-resistant tuberculosis

artículo científico publicado en 2016

World TB Day 2017: Strengthening the fight against TB.

artículo científico publicado en 2017

World distribution of tuberculosis in 2002: short term perspectives

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda